Precogify
Haidian
About Precogify
Precogify offers B-GPS disease-causing gene prediction technology. They cooperate with the data in the early stage of the project to systematically screen tissue-specific disease-causing genes and directly verify and re-test in the queue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $2.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2022)
- Website: zjpkyy.com
- Phone: +86 010-62985872
Industries & Categories
Health Care, Medical, Oncology, Professional Services
Canonical: https://fsome.com/organization/precogify-39350 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.